Kingfa Science & Technology (India) Other Announcement
Kingfa filed CARE Ratings' monitoring report on its Rs.500 crore preferential issue proceeds. Nil deviation from issue objects was reported for the quarter ended September 30, 2026.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
7 announcements with these filters
Kingfa filed CARE Ratings' monitoring report on its Rs.500 crore preferential issue proceeds. Nil deviation from issue objects was reported for the quarter ended September 30, 2026.
Kingfa Science & Technology filed a Q2 FY2026-27 performance update deck with greetings, market outlook and industry auto-production data. No revenue/profit table, order, or transaction is disclosed, so it is routine investor material.
Kingfa Science approved unaudited standalone results for the quarter and half year ended 30 September 2026. Half-year revenue from operations was ₹1,41,165.40 lakhs.
Kingfa disclosed that Nilima Ramrao Shinde ceased as Non-Executive Independent Director on tenure completion, effective 31 October 2026. No monetary value is involved.
Kingfa informed exchanges its Board meeting is scheduled for November 5, 2026, to consider Q1/H1 FY27 unaudited results. Trading window stays closed until 48 hours post-announcement.
Kingfa Science & Technology (India) Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with Regulation 31(1)(b).
Kingfa Science & Technology (India) Ltd concluded its 42nd Annual General Meeting on September 28, 2026, where shareholders considered various business resolutions and financial statements.